These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8272907)

  • 1. Drug abuse in an obstetric population of a midsized city.
    Hawthorne JL; Maier RC
    South Med J; 1993 Dec; 86(12):1334-8. PubMed ID: 8272907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of use of cocaine and other substances in an obstetric population.
    Matera C; Warren WB; Moomjy M; Fink DJ; Fox HE
    Am J Obstet Gynecol; 1990 Sep; 163(3):797-801. PubMed ID: 2403158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug abuse during pregnancy in an inner-city hospital: prevalence and patterns.
    Land DB; Kushner R
    J Am Osteopath Assoc; 1990 May; 90(5):421-6. PubMed ID: 2354963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette Smoking Status and Substance Use in Pregnancy.
    Oga EA; Mark K; Coleman-Cowger VH
    Matern Child Health J; 2018 Oct; 22(10):1477-1483. PubMed ID: 29882032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening.
    Gillogley KM; Evans AT; Hansen RL; Samuels SJ; Batra KK
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1535-42. PubMed ID: 2240103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors related to perinatal substance abuse in a California county.
    Gurnack AM; Paul W
    Percept Mot Skills; 1997 Jun; 84(3 Pt 2):1403-8. PubMed ID: 9229467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-wide estimation of illicit drug use in delivering women: prevalence, demographics, and associated risk factors.
    Vaughn AJ; Carzoli RP; Sanchez-Ramos L; Murphy S; Khan N; Chiu T
    Obstet Gynecol; 1993 Jul; 82(1):92-6. PubMed ID: 8515933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal screening for drugs of abuse: reassessment of current practice in a high-risk area.
    Schulman M; Morel M; Karmen A; Chazotte C
    Am J Perinatol; 1993 Sep; 10(5):374-7. PubMed ID: 8240597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse during pregnancy in a rural population.
    Sloan LB; Gay JW; Snyder SW; Bales WR
    Obstet Gynecol; 1992 Feb; 79(2):245-8. PubMed ID: 1731293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study.
    Ostrea EM; Brady M; Gause S; Raymundo AL; Stevens M
    Pediatrics; 1992 Jan; 89(1):107-13. PubMed ID: 1727992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
    Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ
    J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine abuse during pregnancy: peripartum prevalence and perinatal outcome.
    Neerhof MG; MacGregor SN; Retzky SS; Sullivan TP
    Am J Obstet Gynecol; 1989 Sep; 161(3):633-8. PubMed ID: 2782344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of exposure to drugs of abuse during pregnancy by hair analysis in a Mediterranean island.
    Friguls B; Joya X; Garcia-Serra J; Gómez-Culebras M; Pichini S; Martinez S; Vall O; Garcia-Algar O
    Addiction; 2012 Aug; 107(8):1471-9. PubMed ID: 22296208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic characteristics of drug use during pregnancy: experience in a Nashville hospital.
    Cartwright PS; Schorge JO; McLaughlin FJ
    South Med J; 1991 Jul; 84(7):867-70. PubMed ID: 2068627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic and psychosocial characteristics of substance-abusing pregnant women.
    Hans SL
    Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine use in obstetric patients underreported.
    Sackoff J; Kline J; Kinney A; Grunebaum A
    Am J Public Health; 1992 Jul; 82(7):1043. PubMed ID: 1609909
    [No Abstract]   [Full Text] [Related]  

  • 17. Cocaine use in women from a defined population: prevalence at delivery and effects on growth in infants.
    Weathers WT; Crane MM; Sauvain KJ; Blackhurst DW
    Pediatrics; 1993 Feb; 91(2):350-4. PubMed ID: 8424009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of cocaine and marijuana use among pregnant women in a military health care setting.
    Brunader RE; Brunader JA; Kugler JP
    J Am Board Fam Pract; 1991; 4(6):395-8. PubMed ID: 1767690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of substance abuse in pregnancy among Danish women.
    Rausgaard NL; Ibsen IO; Jørgensen JS; Lamont RF; Ravn P
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):215-9. PubMed ID: 25366294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of substance misuse during early pregnancy in Blyth: an anonymous unlinked study.
    Sanaullah F; Gillian M; Lavin T
    J Obstet Gynaecol; 2006 Apr; 26(3):187-90. PubMed ID: 16698620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.